Richard S. Geary, EVP, Chief Development Officer at IONIS PHARMACEUTICALS INC (IONS), sold 21,226 shares at $50.19 ($1.1M) on 2023-12-14, disclosed to the SEC on 2023-12-18.
Scheduled sale ($1.1M) by EVP, Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.21 | 6,571 | $323K | 30.7% |
| 2 | $49.21 | 6,571 | $323K | 30.7% |
| 3 | $50.19 | 4,042 | $203K | 19.3% |
| 4 | $50.19 | 4,042 | $203K | 19.3% |
| Total | $49.58 avg | 21,226 | $1.1M | 100% |
| Filing → |
| IONS | SELL | 2025-11-03 | $11.9M | — | Filing → |
| IONS | SELL | 2025-10-01 | $7.6M | — | Filing → |
| IONS | SELL | 2025-09-04 | $504K | — | Filing → |